MedTrace Logo

Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence

NCT07038811 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-06-26

No results posted yet for this study

Summary

This observational study aims to evaluate the implementation and use of the Tät®II app for the treatment of urgency and mixed urinary incontinence in women over the age of 18 after contact with ordinary healthcare, as well as its effectiveness. The study aims to answer the following question:

Is treatment via the app effective and feasible after primary care?

Participants will use the app for 15 weeks to treat urgency and mixed urinary incontinence. They will answer online survey questions about their urinary incontinence before, after 15 weeks, and one year after treatment.

Conditions

  • Urgency Incontinence
  • Mixed Incontinence, Urge and Stress

Interventions

DEVICE

Tät®II

The Tät®II app offers a treatment program for women with urge or mixed urinary incontinence. The program includes information on the pelvic floor, urinary incontinence, and factors affecting incontinence; a bladder training program; a pelvic floor muscle training program; and incontinence-related psychoeducation. The app also contains helpful functions, the ability to create reminders, visualization of each training level, a statistics function regarding the number of exercises performed, and feedback on changes in the level of bother due to urinary incontinence during treatment. The Tät®II app is available for download on Google Play and the App Store. Users need a one-time code to access the app, which is provided by the research team after they are included in the study. The app is self-instructive and can be used anywhere; no formal education is necessary. There is no option to communicate through the app.

Sponsors & Collaborators

  • Region Jämtland Härjedalen

    collaborator OTHER

  • Umeå University

    lead OTHER

Principal Investigators

  • Ina Asklund, MD, PhD · Umeå University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-12
Primary Completion
2027-06-01
Completion
2027-06-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07038811 on ClinicalTrials.gov